CryoLife, Inc. (NYSE: CRY) reported Q2 EPS of $0.08, $0.03 better than the analyst estimate of $0.05. Revenue for the quarter came in at $34.69 million versus the consensus estimate of $35.72 million.

For earnings history and earnings-related data on CryoLife, Inc. (CRY) click here.